{
    "2018-05-24": [
        [
            {
                "time": "2023-09-15",
                "original_text": "FDA Confirms September Action Date for Teva's Migraine Drug",
                "features": {
                    "keywords": [
                        "FDA",
                        "Teva",
                        "Migraine",
                        "Drug",
                        "September"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "Why Is Eli Lilly (LLY) Up 2.7% Since Its Last Earnings Report?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "Earnings",
                        "Up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "Merck's Keytruda Shows Survival Benefit in Squamous NSCLC",
                "features": {
                    "keywords": [
                        "Merck",
                        "Keytruda",
                        "Survival",
                        "NSCLC"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "Noteworthy ETF Outflows: IWF, COST, CRM, LLY",
                "features": {
                    "keywords": [
                        "ETF",
                        "Outflows",
                        "IWF",
                        "COST",
                        "CRM",
                        "LLY"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "Is This Little Biotech the Best Migraine Stock to Buy Now?",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Migraine",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-15",
                "original_text": "An Upgrade for This Wellington-Managed Fund of Dividend Payers",
                "features": {
                    "keywords": [
                        "Upgrade",
                        "Wellington-Managed",
                        "Fund",
                        "Dividend"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}